Skip to content
Search

Latest Stories

DHSC seeks views on proposed measures to eradicate modern slavery from NHS supply chain

DHSC proposes measures to eradicate modern slavery from NHS supply chain
getyimages

Public bodies procuring goods and services for the NHS would be required to both identify and mitigate risks of modern slavery

The Department of Health and Social Care (DHSC) has launched a public consultation to gather feedback on government proposals to eliminate modern slavery from the NHS supply chain.

This initiative follows a recent government review which revealed that over 21 per cent of NHS suppliers are at high risk of involving modern slavery in the procurement of medical equipment, particularly surgical instruments, gloves, gowns, uniforms, and face masks.


The proposed measures would require public bodies procuring goods and services for the NHS to work with suppliers to identify risks and put forward solutions.

These new regulations would apply to all public bodies procuring health goods and services, including NHS trusts, integrated care boards, and local authorities.

Health Secretary Wes Streeting said: “The NHS is a public service built on compassion and equality, values which are completely antithetical to the heinous evil of modern slavery.”

“These new measures will ensure vital checks are made and public bodies act to stamp out the crimes of slavery and human trafficking.”

He also stated that his government will ensure the NHS leads the fight against modern slavery.

Jacqui Rock, chief commercial officer at NHS England, underscored the need for such measures stating, “Modern slavery is insidious and needs to be eradicated from the NHS supply chain.”

While NHS’s procurement already follows the government’s standard selection questionnaire to address modern slavery risk, she stressed that "there is much more to do.”

“We have a responsibility to ensure a zero-tolerance policy to modern slavery - and the more stakeholders that respond to this consultation will help strengthen these measures and help us wipe out this crime in the NHS supply chain,” she added.

The government is seeking views on the proposals from public bodies, suppliers, trade associations, interest groups, patients, and the wider public, with responses to be submitted by 13 February 2025.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less